CVS Caremark today issued a report that highlight research the company is conducting around medication adherence, including one study that reviews and compares state-by-state adherence rates for patients managing four chronic diseases. The State of the States: Adherence Report is a first-of-its kind study that looks at how patients in all 50 states are complying with their doctors’ orders about taking medication. The review of CVS Caremark’s pharmacy benefit management claims data focused on four common disease states – hypertension, high cholesterol, diabetes and depression – diseases that make up a large portion of pharmacy spend by health plan sponsors. Read more
CVS Caremark Publishes State of the States: Adherence Report
More from GeneralMore posts in General »
- WHO Report: Rise in Caesarean Section Rates, Amid Growing Inequalities in Access
- Peterson-KFF Health System Tracker Brief: Results of Effectiveness of Health Price Transparency Rule
- AIHW: International Health Data Comparisons 2020
- Diagnostic Errors, Maternal Health Top ECRI’s 2020 Patient Safety Concerns
- Calls for Medical Devices Registry in UK to Reduce Risk of Patient Harm